Cordyceps

TL;DR

Profound Qi and Yang tonic. Cordyceps sinensis (Cs-4 standardized extract) with cordycepin (3’-deoxyadenosine) as primary active. Clinically validated 10.5% increase in metabolic threshold and 8.5% increase in ventilatory threshold in healthy older adults (50–75 yr, 12-week DB-RCT). Activates AMPK + inhibits PI3K/AKT/mTOR → metabolic conservation shift. Short cordycepin half-life is overcome by stacking with Schisandra (CYP3A4/P-gp modulation).

Why it matters for Vitals

Cordyceps directly improves oxygen kinetics (VO2-related metrics), ATP production, and metabolic threshold — all directly relevant to Vitals body composition and recovery coaching. The 10.5% metabolic threshold improvement in healthy 50–75 year olds is a meaningful athletic performance signal. AMPK activation supports metabolic flexibility and may improve fasting metrics. The Schisandra stacking synergy is a practical, evidence-backed protocol.

Key Facts

Status	OTC; not scheduled
Class	TCM Superior Herb — Qi/Yang tonic
Primary mechanism	Cordycepin → AMPK activation + PI3K/AKT/mTOR inhibition → metabolic conservation shift
Key benefits	10.5% metabolic threshold ↑, 8.5% ventilatory threshold ↑, ATP enhancement, pulmonary/renal axis support
Dosing	1,000–3,000 mg/day Cs-4 or C. militaris (standardized ≥0.14% cordycepin + adenosine)
Timing	Morning/pre-workout, 45 min before exercise — maximizes ATP/VO2 peak + AMPK activation. Avoid past 2 PM (adenosine-mediated insomnia risk)
Cycling	8 weeks on, 2 weeks off
Main risks	Documented hypoglycemic activity → additive with insulin/metformin; short cordycepin half-life requires Schisandra stacking
Evidence level	Moderate — strong single DB-RCT (n=20, 12 weeks); pharmacokinetic stacking synergy characterized

Mechanism Summary

AMPK/mTOR modulation: Cordycepin activates AMPK phosphorylation → simultaneously inhibits PI3K/AKT/mTOR cascade → shifts cellular metabolism from anabolic proliferation to metabolic conservation + DNA repair.

ATP:Pi ratio enhancement: Directly increases intracellular ATP availability — confirmed by 10.5% metabolic threshold improvement.

Oxygen kinetics: Increases metabolic threshold (lactate buffering point) + ventilatory threshold → substantially enhanced aerobic capacity + oxygen utilization.

Adenosine receptor modulation: Maintains sleep homeostasis; however, adenosine deaminase rapidly degrades cordycepin systemically (short half-life).

Clinical Evidence

Cs-4, Double-blind RCT, 12 weeks, n=20, healthy adults 50–75:

• 10.5% increase in metabolic threshold (lactic acid accumulation point) — p<0.02
• 8.5% increase in ventilatory threshold — p<0.05 (implied)
• Confirms substantially enhanced aerobic capacity + oxygen kinetics

Pharmacokinetic Stacking — Schisandra Synergy

Cordycepin has very short systemic half-life (rapid adenosine deaminase degradation). Schisandra lignans → modulate adenosine deaminase + intestinal P-glycoprotein efflux → extended cordycepin bioavailability. Stack Cordyceps + Schisandra for clinically meaningful cordycepin levels.

Drug Interactions

Drug	Interaction
Insulin, metformin	Additive hypoglycemia — monitor glucose closely

Species Note

Cs-4 (C. sinensis standardized extract) has most clinical evidence. C. militaris has higher cordycepin content but less human RCT data. Both are used; Cs-4 preferred for clinical translation.

Inside this hub

• Cordycepic acid (D-mannitol) specifics — secondary
• Ergosterol derivative details — too granular
• Fermentation organism selection — procedural, stays here

Related notes

• TCM Superior Herbs — parent system
• Schisandra — pharmacokinetic synergy (extends cordycepin half-life); co-stacking critical
• Astragalus — comparison: both Qi tonics, AMPK; Astragalus = TERT/hematopoietic, Cordyceps = ATP/VO2
• Reishi — comparison: both Shen; Cordyceps = AMPK/ATP, Reishi = NK/GABA
• AMPK — shared upstream mechanism; mTOR — shared inhibition pathway
• Mitophagy — Cordyceps AMPK → autophagy/mitochondrial quality control
• Exercise Mimetics — AMPK/mTOR/ATP profile overlaps with exercise mimetic concept